Ethambutol neurophathy: clinical and electroneuromyographic studies.
Clinical features including changes in the peripheral nerve conduction were analzyed in 10 cases with ethambutol neuropathy. There were abnormalities in the visual field in seven and optic atrophy in five of 10 cases. Seven of 10 cases complained of numbness in the lower limbs. The age of onset and dose of ethambutol the patients continue to take after the occurrence of visual impairment were found to be important in determining the severity of neurological symptoms. A functional disturbance was more conspicuous in ethambutol neuropathy, particularly in the sensory system than in the motor system so far as the peripheral nerve conduction was serially examined. Some cases still had serious optic disturbances even about seven years after the onset of the disease and the presence of irreversible lesions was suspected.
D000293:Adolescent; D000368:Aged; D001284:Atrophy; D004576:Electromyography; D004977:Ethambutol / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009431:Neural Conduction; D009900:Optic Nerve / Q000473:pathology; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced* / Q000503:physiopathology; D013979:Tibial Nerve / Q000503:physiopathology; D014786:Vision Disorders / Q000139:chemically induced / Q000503:physiopathology; D014794:Visual Fields / Q000187:drug effects
D004977:Ethambutol